The performance of companies tied to the drug's past presents a challenging investment landscape. While the initial surge generated substantial profits , generic alternatives have significantly diminished https://bookmarkstumble.com/story23687347/copyright-s-flagship-product-and-big-pharma-a-speculative-investment